• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 13.95
  • VXN 18.04
  • VXO -
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)

Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company?s cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions. Its inflation devices, such as IntelliSystem, Monarch, and Basix COMPAK are used for measuring pressures during balloon and stent deployment. Merit Medical offers hemostasis valves; vascular retrieval devices; vascular access products; and diagnostic catheters, guide wires, and torque devices. The company also offers angiography and angioplasty accessories used during minimally invasive diagnosis and for the treatment of coronary artery and peripheral disease; safety and waste management systems to help avoid accidental exposure to contaminated fluids; and drainage catheters and accessories for nephrostomy, abscess, and other drainage procedures. In addition, it offers paracentesis and pericardiocentesis catheters to provide clinicians with a safe and convenient alternative for paracentesis procedures; therapeutic infusion catheters for the treatment of thrombus formation in the peripheral vessels of the body; multipurpose microcatheters for the delivery of interventional devices or therapeutic pharmaceuticals into selected blood vessels; and products for dialysis and interventional nephrology. Further, the company offers obesity-related products; gastroenterology and pulmonary products, such as non-vascular stents and bi-polar probes; and specialty procedure products, such as discography products and pressure sensors. It offers its products primarily to radiologists, anesthesiologists, physiatrists, neurologists, nephrologists, vascular surgeons, thoracic surgeons, technicians, and nurses. Merit Medical sells its products through direct sales forces, distributors, OEM partners, custom packagers, and packers. The company was founded in 1987 and is based in South Jordan, Utah.

MMSI (Merit Medical Systems Inc)
Last Trade 30.335 Date 9/19/2019
Change % 1.36 % Price Change 0.41
Open 29.92 52 Week High 66.34
High 30.37 52 Week Low 25.67
Low 29.79 Type stock
Volume 29118 Average Volume 825512
Prev Close 29.93 Stock Exchange NASDAQ
Bid 30.29 Ask 30.38
Bid Size 1 Ask Size 1
1st Yr Estimated EPS Growth 1.6206 2nd Yr Estimated EPS Growth 0.15
2 Years Forward Earning Yield 0.0768 2 Years Forward PE Ratio 13.013
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 17.2302 Book Value Yield 0.5757
Buy Back Yield CAPE Ratio 52.1423
Cash Return 0.012 Cash Flow per Share 1.5518
Cash Flow Yield 0.0518 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0234 EV/EBIT 36.2333
EV/EBITDA 14.4198 EV / Free Cash Flow 126.5783
EV / Forward EBIT EV / Forward EBITDA 10.4863
EV / Forward Revenue 1.9111 EV / Pre Tax Income 44.2553
EV / Revenue 2.2127 EV / Total Asset 1.2092
Expected Dividend Growth Rate Free Cash Flow per Share 0.2953
Free Caash Flow Ratio 101.371499 Free Cash Flow Yield 0.0099
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield 0.0668 Forward PE Ratio 14.9701
Forward Return on Asset 0.0636 Forward Return on Equity 0.1161
Normalized PE Ratio 39.217947 Payout Ratio 0.0
PB Ratio 1.737066 PB Ratio 10 Year Growth -0.038284
PB Ratio 3 Year Growth 3.196646 Cash Ratio 3 Year Average 6966.8893
Price to Cash Flow Ratio 19.287261 PEG Payback 8.072
PEG Ratio 1.2471 PE Ratio 42.757143
PE Ratio 10 Year Average PE Ratio 10 Year Growth 0.058252
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg 82.250633
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth 0.096826
Free Cash Flow Ratio 3 Year Avg 156.759146 Price Change 1 Month 0.860552
Price to Cash Ratio 46.938361 Price / EBITDA 11.548273
Price to Sales Ratio 1.772097 Price to Sales Ratio 10 Year Growth -0.022992
Price to Sales Ratio 3 Year Avg 2.960411 Price to Sales Ratio 5 Year Avg
Sale per Share 16.8896 Sales Yield 0.5643
Sustainable Growth Rate 0.0471 Tangible Book Value per Share 2.4009
Tangible Book Value per Share 3 year Avg 4.3397 Tangible Book Value per Share 5 year Avg 3.9253
Total Asset per Share 31.4685 Total Yield
Working Capital per Share 4.5382 Working Capital per Share 3 Year Avg 3.8831
Working Capital per Share 5 Year Avg 3.3329 Beta 1.2994